Abstract
We appreciate the reviewer's comments. Our present study was mainly designed to assess the utility of fluorescence in situ hybridization (FISH) as a predictor of the residual tumor load after transurethral resection (TUR). Depending on the histopathologic findings of the initial TUR, the series included 14 patients with Stage Ta, low-grade urothelial carcinoma (UC) and 8 patients with Stage T2 tumors. We agree it is important to decrease the number of patients who require repeat TUR according to the results of the first TUR.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
